Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats

被引:94
作者
Nagano, H
Nadeau, KC
Takada, M
Kusaka, M
Tilney, NL
机构
[1] CHILDRENS HOSP,MED CTR,DEPT PEDIAT,BOSTON,MA 02115
[2] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT SURG,SURG RES LAB,BOSTON,MA 02115
关键词
D O I
10.1097/00007890-199704270-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The initial (0-24 hr), early (3-5 days), and late (7-14 days) events occurring in LBNF1 renal allografts transplanted into Lew recipients were examined to define precisely the sequential cellular and molecular kinetics during acute rejection. Grafts and spleens were harvested at 3, 6, 12, and 24 hr, and at 3, 5, 7, and 14 days and processed for morphology, immunohistology, and reverse transcriptase-polymerase chain reaction. Various factors (mRNA) were up-regulated sequentially in the allografts over time. In the initial phase, E-selectin and complement (C1 and C3) expression was noted within 6 hr, peaking by 24 hr. RANTES (regulated upon activation, normal T cell expressed and secreted) increased within 6 in, and then again between 3 and 6 days. By immunohistology, MHC class II was up-regulated consistently after day 1. Intercellular adhesion molecule-1 expression increased after day 3; lymphocyte function-associated antigen-1(+) infiltrating leukocytes peaked at day 5. Infiltrating CD8(+) T lymphocytes increased strikingly between days 1 and 3, peaking at day 5; CD4(+) cells infiltrated more slowly until day 5. The kinetics of ED1(+) macrophages were similar to those of lymphocyte function-associated antigen-1(+) cells. The CD4(+) T cell-derived product, interleukin (IL)-2, peaked at 7 days. Interferon-gamma increased progressively up to 14 days. By 3 days, the macrophage-associated factor, transforming growth factor-beta, peaked; this was followed by increased IL-6 expression by day 5. IL-1, tumor necrosis factor-alpha, and inducible nitric oxide synthase increased slowly until day 7, declining thereafter. Endothelin increased progressively over the 14-day follow-up period. Cytokine dynamics occurring in host spleen were similar to those noted in the allografts. Although acute rejection is primarily T cell mediated, adhesion molecules, macrophages, and their associated products may influence initial and later changes. The brisk expression of complement, E-selectin, and RANTES within the first few hours after engraftment may occur secondary to ischemic injury and trigger subsequent immunological events. Macrophages and their products may play a larger role in the process than hitherto appreciated.
引用
收藏
页码:1101 / 1108
页数:8
相关论文
共 63 条
[1]  
Abbas AK, 1994, CELLULAR MOL IMMUNOL, P293
[2]   EXPRESSION AND TISSUE LOCALIZATION OF DONOR-SPECIFIC COMPLEMENT C3 SYNTHESIZED IN HUMAN RENAL-ALLOGRAFTS [J].
ANDREWS, PA ;
FINN, JE ;
LLOYD, CM ;
ZHOU, WD ;
MATHIESON, PW ;
SACKS, SH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (04) :1087-1093
[3]  
BALDWIN WM, 1979, LAB INVEST, V40, P695
[4]   COMPLEMENT IN ORGAN-TRANSPLANTATION - CONTRIBUTIONS TO INFLAMMATION, INJURY, AND REJECTION [J].
BALDWIN, WM ;
PRUITT, SK ;
BRAUER, RB ;
DAHA, MR ;
SANFILIPPO, F .
TRANSPLANTATION, 1995, 59 (06) :797-808
[5]   ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1 - AN INDUCIBLE RECEPTOR FOR NEUTROPHILS RELATED TO COMPLEMENT REGULATORY PROTEINS AND LECTINS [J].
BEVILACQUA, MP ;
STENGELIN, S ;
GIMBRONE, MA ;
SEED, B .
SCIENCE, 1989, 243 (4895) :1160-1165
[6]  
BILLUPS KL, 1995, J LAB CLIN MED, V126, P580
[7]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[8]   EXTRAHEPATIC SYNTHESIS OF C6 IN THE RAT IS SUFFICIENT FOR COMPLEMENT-MEDIATED HYPERACUTE REJECTION OF A GUINEA-PIG CARDIAC XENOGRAFT [J].
BRAUER, RB ;
LAM, TT ;
WANG, DJ ;
HORWITZ, LR ;
HESS, AD ;
KLEIN, AS ;
SANFILIPPO, F ;
BALDWIN, WM .
TRANSPLANTATION, 1995, 59 (07) :1073-1076
[9]  
BROAD TE, 1993, ANIM GENET, V24, P415
[10]   INTERLEUKIN-2 MEDIATES STIMULATION OF COMPLEMENT-C3 BIOSYNTHESIS IN HUMAN PROXIMAL TUBULAR EPITHELIAL-CELLS [J].
BROOIMANS, RA ;
STEGMANN, APA ;
VANDORP, WT ;
VANDERARK, AAJ ;
VANDERWOUDE, FJ ;
VANES, LA ;
DAHA, MR .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (02) :379-384